Nytimes

FDA Approves Journavx Drug to Treat Pain Without Addiction Risk

The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.

Jan 31, 2025 - 04:00
FDA Approves Journavx Drug to Treat Pain Without Addiction Risk
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.
Read More

Tags:

Previous Article

Loretta Ford, ‘Mother’ of the Nurse Practitioner Field, Dies at 104

Next Article

RFK Jr. Says He Won’t Keep Financial Stake in HPV Vaccine Lawsuits

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

At Long Last, the Surge in S.T.I.s May Be Leveling Off

At Long Last, the Surge in S.T.I.s May Be Leveling Off

Nov 12, 2024

U.S. Terminates Funding for Polio, H.I.V., Malaria and Nutrition Programs Around the World

U.S. Terminates Funding for Polio, H.I.V., Malaria and ...

Feb 28, 2025

Trump’s Foreign Aid Freeze Leaves Millions Without HIV Treatment

Trump’s Foreign Aid Freeze Leaves Millions Without HIV ...

Feb 6, 2025